DE602005026705D1 - Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose - Google Patents

Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose

Info

Publication number
DE602005026705D1
DE602005026705D1 DE602005026705T DE602005026705T DE602005026705D1 DE 602005026705 D1 DE602005026705 D1 DE 602005026705D1 DE 602005026705 T DE602005026705 T DE 602005026705T DE 602005026705 T DE602005026705 T DE 602005026705T DE 602005026705 D1 DE602005026705 D1 DE 602005026705D1
Authority
DE
Germany
Prior art keywords
treatment
pharmaceutical composition
invasive lung
aspergillosis
mug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026705T
Other languages
English (en)
Inventor
Puranam Usha Sarma
Taruna Madan Gupta
Savneet Kaur
Steffen Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of DE602005026705D1 publication Critical patent/DE602005026705D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602005026705T 2004-12-23 2005-12-22 Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose Active DE602005026705D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2534DE2004 2004-12-23
PCT/IN2005/000429 WO2006067807A1 (en) 2004-12-23 2005-12-22 Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis

Publications (1)

Publication Number Publication Date
DE602005026705D1 true DE602005026705D1 (de) 2011-04-14

Family

ID=35953907

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026705T Active DE602005026705D1 (de) 2004-12-23 2005-12-22 Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose

Country Status (6)

Country Link
US (1) US20090088364A1 (de)
EP (1) EP1833502B1 (de)
AT (1) ATE499945T1 (de)
DE (1) DE602005026705D1 (de)
DK (1) DK1833502T3 (de)
WO (1) WO2006067807A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20317914U1 (de) 2003-11-19 2004-12-30 Weh, Erwin Betätigungsvorrichtung für eine Schnellanschlusskupplung
CN110251841B (zh) * 2019-06-13 2021-05-04 中国科学院苏州生物医学工程技术研究所 用于光治疗的波长配置方法、光源配置方法、一种光源

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein
KR100497849B1 (ko) * 1997-08-21 2005-06-29 다카라 바이오 가부시키가이샤 제암제
DE60009896T2 (de) * 1999-05-14 2005-04-21 Steffen Thiel Neue indikationen für mannan-binding lectin (mbl) zur behandlung von immungeschwächten patienten
EP1303288A1 (de) * 2000-07-13 2003-04-23 Natimmune A/S Mannan-bindendes lektin (mbl) zur behandlung von infektionen in tnf alphabehandelte individen
CN100447150C (zh) * 2001-10-19 2008-12-31 纳蒂芒公司 凝集素的分离方法
CN1646152A (zh) * 2002-04-24 2005-07-27 昆士兰医学研究学院理事会 甘露糖结合凝集素及其应用
US20050137126A1 (en) * 2003-04-09 2005-06-23 Natlmmune A/S Treatment of SARS in individuals

Also Published As

Publication number Publication date
ATE499945T1 (de) 2011-03-15
EP1833502B1 (de) 2011-03-02
DK1833502T3 (da) 2011-06-20
EP1833502A1 (de) 2007-09-19
US20090088364A1 (en) 2009-04-02
WO2006067807A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
AP1763A (en) Pulmonary administration of chemically modified insulin
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
RS54707B1 (en) TREATMENT OF CROWN LAKVINIMOD DISEASE
MY143795A (en) Tetrahydropyridoindole derivatives
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
SI1909843T1 (sl) Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
CY1112184T1 (el) Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
JP2009500045A5 (de)
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
DE602004030604D1 (de) N-(5-adamantane-1-yl-methoxy-pentyl)desoxynojirimycin oder eines pharmazeutischen salzes davon zur verwendung bei der behandlung der insulinresistenz
DE602005026705D1 (de) Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose
ATE417599T1 (de) Pharmazeutische zubereitung zur intranasalen applikation von proteinen, enthaltend chitosan oder eines seiner derivate
DE602005023742D1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten